广发证券(01776) - 2022 Q3 - 季度财报

Financial Performance - Total operating revenue for Q3 2022 was CNY 4,810,765,517.92, a decrease of 45.72% compared to the same period last year[4] - Net profit attributable to shareholders for Q3 2022 was CNY 1,036,209,408.12, down 62.35% year-on-year[4] - Basic earnings per share for Q3 2022 was CNY 0.12, a decline of 66.67% compared to the same period last year[4] - The company reported a decrease in net profit excluding non-recurring items to CNY 1,051,804,545.69, a drop of 57.27% year-on-year[4] - Total operating revenue for the current period was approximately ¥17.52 billion, a decrease of 34.7% compared to ¥26.87 billion in the previous period[17] - Net profit for the current period was approximately ¥5.89 billion, a decline of 38.5% from ¥9.55 billion in the previous period[18] - Earnings attributable to shareholders of the parent company for the current period were approximately ¥5.23 billion, down 39.5% from ¥8.64 billion in the previous period[18] - The company reported a total comprehensive income of approximately ¥6.25 billion, a decrease of 32.4% from ¥9.23 billion in the previous period[18] - Basic and diluted earnings per share for the current period were both ¥0.67, compared to ¥1.13 in the previous period[18] Assets and Liabilities - Total assets as of September 30, 2022, reached CNY 590,256,779,447.62, an increase of 10.15% from the end of the previous year[4] - Total liabilities increased significantly, with short-term borrowings rising by 99.18% to CNY 1,825,587,949.17 from CNY 916,545,300.84[7] - Total liabilities as of September 30, 2022, reached approximately ¥467.80 billion, an increase of 10.1% from ¥425.05 billion as of December 31, 2021[15] - Total equity as of September 30, 2022, was approximately ¥122.45 billion, up from ¥110.80 billion as of December 31, 2021, reflecting a growth of 10.5%[16] Cash Flow - Cash flow from operating activities for the year-to-date period was CNY 19,667,347,765.31[4] - The company reported a net cash inflow from operating activities of CNY 19,667,347,765.31, a significant improvement from a net outflow of CNY 7,950,521,929.26[8] - Operating cash inflow for the current period reached ¥94.18 billion, an increase from ¥59.73 billion in the previous period, reflecting a growth of approximately 57.8%[19] - Net cash flow from operating activities was ¥19.67 billion, a significant recovery from a negative ¥7.95 billion in the previous period[19] - Cash inflow from financing activities totaled ¥81.87 billion, compared to ¥75.08 billion in the prior period, indicating an increase of about 9.5%[20] - Cash outflow for debt repayment was ¥65.45 billion, a substantial increase from ¥27.98 billion in the previous period[20] - The ending cash and cash equivalents balance was ¥141.48 billion, down from ¥150.11 billion at the end of the previous period[20] Shareholder Information - The company’s total share capital as of the last trading day before disclosure was 7,621,087,664 shares[4] - The number of common shareholders at the end of the reporting period was 243,023, including 241,523 A-share shareholders and 1,500 H-share shareholders[9] - The largest shareholder, Hong Kong Central Clearing Limited, holds 22.31% of shares, totaling 1,700,116,650 shares[10] - The company’s major shareholder, Jilin Aodong Pharmaceutical Group, increased its stake to 18.56% after acquiring an additional 84.14 million H-shares[12] Other Financial Metrics - Non-recurring gains and losses for Q3 2022 totaled CNY -15,595,137.57, with a year-to-date total of CNY 519,309,649.77[5] - The weighted average return on net assets decreased to 0.90%, down 1.80 percentage points from the previous year[4] - Investment income decreased by 64.49% to CNY 2,108,391,475.71 from CNY 5,937,011,273.13[8] - Other income fell by 35.97% to CNY 769,636,293.88 from CNY 1,201,963,340.61[8] - The company’s total operating expenses for the current period were approximately ¥10.65 billion, a decrease of 28.5% from ¥14.88 billion in the previous period[17] - The company’s investment income for the current period was approximately ¥2.11 billion, down 64.5% from ¥5.94 billion in the previous period[17]